Bionano Genomics Inc (BNGO) — Financial Flexibility Index
Bionano Genomics Inc (BNGO) has a Financial Flexibility Index of -0.14x as of December 2025. Free cash flow of $-4.17 Million (operating CF $-4.17 Million minus capex $0.00) represents 0% of total liabilities ($29.16 Million). Check asset allocation strategy of Bionano Genomics Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bionano Genomics Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Bionano Genomics Inc across 10 annual periods. See BNGO working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Bionano Genomics Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Bionano Genomics Inc. For the full company profile including market capitalisation, see Bionano Genomics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.56x | $-16.34 Million | $-16.34 Million | $29.16 Million | ▲ +66.4% |
| 2024 | -1.67x | $-68.82 Million | $-68.92 Million | $41.30 Million | ▼ -59.6% |
| 2023 | -1.04x | $-123.49 Million | $-125.18 Million | $118.25 Million | ▲ +50.1% |
| 2022 | -2.09x | $-121.51 Million | $-124.82 Million | $58.10 Million | ▼ -18.7% |
| 2021 | -1.76x | $-70.47 Million | $-71.93 Million | $39.98 Million | ▼ -32.8% |
| 2020 | -1.33x | $-33.66 Million | $-38.31 Million | $25.37 Million | ▼ -19.7% |
| 2019 | -1.11x | $-29.47 Million | $-29.53 Million | $26.59 Million | ▲ +17.1% |
| 2018 | -1.34x | $-19.61 Million | $-19.94 Million | $14.67 Million | ▼ -307.8% |
| 2017 | -0.33x | $-19.80 Million | $-20.82 Million | $60.37 Million | ▲ +37.7% |
| 2016 | -0.53x | $-22.15 Million | $-23.50 Million | $42.05 Million | — |